Monomethyl auristatin E (GMP)

Overview

Monomethyl auristatin E (MMAE) (GMP) is Monomethyl auristatin E ( HY-15162 ) produced by using GMP guidelines. Monomethyl auristatin E is a tubulin polymerization inhibitor.

Application

Products | Products > GMP Small Molecules | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Non-Small Cell Lung Cancer | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Disease Areas > Metastatic Breast Cancer | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > ADC Payloads | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-15162G
• CAS No.: 474645-27-7
• Molecular Formula: C39H67N5O7
• Molecular Weight: 717.98
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source